Morepen Laboratories has set September 19, 2026, as the record date.

This is to identify shareholders eligible for the final dividend for the financial year ending March 31, 2026. The dividend payout is contingent upon shareholder approval at the upcoming 41st Annual General Meeting, which is scheduled for September 26, 2026. The company's Board also approved the financial results for the quarter and an extension for hiving off its Medical Devices business.